11.5
+0.72 (+6.68%)
No Fundamental Analysis report for ORPN not available.
Bio Blast Pharma Ltd. / ORPN FAQ
What is the fundamental rating for ORPN stock?
ChartMill assigns a fundamental rating of 2 / 10 to ORPN.
What is the valuation status for ORPN stock?
ChartMill assigns a valuation rating of 2 / 10 to Bio Blast Pharma Ltd. (ORPN). This can be considered as Overvalued.
What is the profitability of ORPN stock?
Bio Blast Pharma Ltd. (ORPN) has a profitability rating of 1 / 10.
What is the expected EPS growth for Bio Blast Pharma Ltd. (ORPN) stock?
The Earnings per Share (EPS) of Bio Blast Pharma Ltd. (ORPN) is expected to decline by -100% in the next year.
Can you provide the dividend sustainability for ORPN stock?
The dividend rating of Bio Blast Pharma Ltd. (ORPN) is 0 / 10 and the dividend payout ratio is 0%.